Notably, gefitinib treatment also induces FGFR2 protein in MCF-7 cells, a breast cancer cell line, and 3 different head and neck cancer cell lines (UMSCC2, UMSCC8, and HN31, Figure S1). This evidence concerns the gene FGFR2 and head and neck cancer.